Glycosylated hemoglobin as a forecast factor of progressing of diabetic nephropathy in patients with diabetes type 1.

N. O. Pertseva, D. I. Chub

Abstract


The aim of the study was to propose a mathematical model for prediction of development of diabetic nephropathy in patients with diabetes mellitus by determining the level of glycosylated hemoglobin - as a factor in the development and progression of diabetic nephropathy. A survey of 136 patients with type 1 diabetes was performed in the endocrinology department of the OSH «Clinic of the Medical Academy», Dnipro in 2016-2017. Clinical laboratory examination included: determination of the level of glycosylated hemoglobin (HbA1c), level of blood creatinine, level of albuminuria. The GFR was calculated by the formula CKD-EPI.The obtained results of the study, using methods of correlation and regression analysis, show a clear correlation between the GFR score in patients with diabetes mellitus and the level of glycosylated hemoglobin. Statistical methods of analysis have shown that the level of glycosylated hemoglobin can be considered as an early predictor of development of diabetic nephropathy. The mathematical equation of prognosis for the onset of diabetic nephropathy can be used to determine the prognosis for the development of diabetic nephropathy in diabetes mellitus patients in clinical practice for the timely inclusion of patients with a high prognostic risk in a group requiring more stringent glycemic control.


Keywords


diabetes mellitus; diabetic nephropathy; glomerular filtration rate, lipidogram, albuminuria

Full Text:

PDF

References


Moskalenko VF. [Biostatistics]. Kyiv, Kniga plyus. 2009;184. Ukrainian.

Pan'kіv VІ. [Symposium N 156 "Diabetes Melli­tus: Definition, Classification, Epidemiology, Risk Fac­tors"]. International Endocrinology Journal. 2013;7:95-104. Ukrainian.

Rebrova OYu. [Statistical analysis of medical data. Application of the STATISTICA application pac­kage]. Moskva, Media-Sfera. 2006;312. Russian.

Sokolova LK. [Prevalence of diabetes mellitus inUkraine[Electronic resource] Telegraf. 2015. Available from: https://telegraf.com.ua/zhizn/zdorove/2195284-ras­prostranennost-saharnogo-diabeta-v-ukraine-uvelichilas-v-poltora-raza.html Ukrainian.

Khardle V. [Applied non-parametric regression]. Moskva, Mir. 1993;349.

Brenner ВМ. The hyperfiltration theory: a para­digm shift in nephrology. Kidney Int. 1996;49(6):1774-7.

Diabetes Key facts. [Electronic resource]. World Health Organization. Available from: http://www.who.int/­mediacentre/factsheets/fs312/en/.

DCCT/EDIC Research Group, Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes N. Engl. J. Med. 2011;365:2366-76.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419-30.

Patel А. Effects of a fixed combination of perin­dopril and indapamide on macrovascular and mic­rovascular outcomes in patients with type 2 diabetes mel­litus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829-40.

Frische S. Glomerular filtration rate in early diabetes: ongoing discussions of causes and mechanisms. J. Nephrol. 2011;24(5):537-40.

Okada R. Glomerular hyperfiltration in predia­betes and prehypertension. Nephrol Dial Transplant. 2012;27(5):1821-5.

KDOQIUScommentary on the 2012 KDIGO clinical practice guideline for the evaluation and ma­nagement of CKD. Am J Kidney Dis. 2014;63:713-35.

KrolewskiAS.Genetics of diabetic nephropathy: how far are we from finding susceptibility genes? Adv. Nephrol. Necker. Hosp. 2010;31:295-315.

Lorenzi M. Glucose toxicity in the vascular complications of diabetes: The cellular perspective. Diabet. Metab. Rev. 2009;8:85-103.

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases,Bethesda,MD.US. Renal data system annual data report: atlas of end-stage renal disease in theUnited States; 2010.

NKF-KDOQI Guidelines on Diabetes and CKD. Am. J. Kid. Dis. 2013;2(2):12-143.

Porush JM. Hypertension, diabetes mellitus and nephropathy.London. Sience Preess. 2010;9-12.

US Hypertension Management Guidelines: A Re­view of the Recent Past and Recommendations for the Fu­tu­re. [Electronic resource]. J. Am Heart Assoc. 2015. Avai­lable from: http://jaha.ahajournals.org/content/4/12/e002315.


GOST Style Citations


1.       Москаленко В.Ф. Біостатистика / В.Ф. Моска­ленко, О.П. Гульчій, М.В. Голубчико. – Київ: Книга плюс, 2009. – 184 с.

2.       Паньків В.І. Симпозіум № 156 «Цукровий діабет: визначення, класифікація, епідеміологія, фак­тори ризику» / В.І. Паньків // Міжнар. ендокринол. журнал. – 2013. – № 7. – С. 95-104.

3.       Реброва О.Ю. Статистический анализ меди­цинских данных. Применение пакета прикладных программ STATISTICA / О.Ю. Реброва. – Москва: Медиа-Сфера, 2006. – 312 с.

4.       Соколова Л.К. Распространенность сахарного диабета в Украине [Електронний ресурс] / Л.К. Соко­лова // Телеграф. – 2015. – Режим доступу до ресурсу: https://telegraf.com.ua/zhizn/zdorove/2195284-rasprostra­nennost-saharnogo-diabeta-v-ukraine-uvelichilas-v-polto­ra-raza.html.

5.       Хардле В. Прикладная непараметрическая рег­рессия / В. Хардле [пер. с англ.]. – Москва: Мир, 1993. – 349 с.

6.       Brenner В.М. The hyperfiltration theory: a pa­radigm shift in nephrology / B.M. Brenner, E.V. Lawler, H.S.Mackenzie // Kidney Int. – 1996. – Vol. 49, N 6. – Р. 1774-1777.

7.       Diabetes Key facts [Електронний ресурс] // World Health Organization – Режим доступу до ресур­су: http://www.who.int/mediacentre/fact­sheets/fs312/en/.

8.       DCCT/EDIC Research Group, Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes / I.H. de Boer, W. Sun, P.A. Cleary [et al.] // N. Engl. J. Med. – 2011. – Vol. 365. – P. 2366-2376.

9.       Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial /F. Ismail-Beigi, T. Craven, M.A. Banerji [et al.] // Lancet. – 2010. – Vol. 376. – P. 419-430.

10.    Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular out­comes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial / А. Patel, S. Mac Mahon, J. Chalmers [et al.] // Lancet. – 2007. – Vol. 370. – P. 829-840.

11.    Frische S. Glomerular filtration rate in early dia­betes: ongoing discussions of causes and mechanisms / S. Fri­sche // J. Nephrol. – 2011. – Vol. 24, N 5. – Р. 537-540.

12.    Glomerular hyperfiltration in prediabetes and prehypertension / R. Okada, Y. Yasuda, K. Tsushita [et al.] // Nephrol Dial Transplant. – 2012. – Vol. 27, N 5. – Р. 1821-1825.

13.    KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and ma­nagement of CKD / L.A. Inker, B.C. Astor, C.H. Fox [et al.] // Am. J. Kidney Dis. – 2014. – Vol. 63. – P. 713-735.

14.    Krolewski A.S. Genetics of diabetic nephropathy: how far are we from finding susceptibility genes? / A.S. Krolewski // Adv.Nephrol. Necker. Hosp. – 2010. – Vol. 31. – P. 295-315.

15.    Lorenzi M. Glucose toxicity in the vascular com­plications of diabetes: The cellular perspective / M. Lo­renzi // Diabet. Metab. Rev. – 2009. – Vol. 8. – P. 85-103.

16.    National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. US Renal data system annual data report: atlas of end-stage renal disease in the United States. – 2010.

17.    NKF-KDOQI Guidelines on Diabetes and CKD // Am. J. Kid. Dis. —2013. — N 2, Suppl 2. — S. 12-S. 143.

18.    Porush J.M. Hypertension, diabetes mellitus and nephropathy / J.M. Porush, P.F. Faubert. – London: Sien­ce Preess, 2010. – Р. 9-12.

19.    US Hypertension Management Guidelines: A Re­view of the Recent Past and Recommendations for the Future [Електронний ресурс] / L.C. Kovell, H.M. Ah­med, S. Misra [et al.] // J. Am. Heart. Assoc. – 2015. – Режим доступу до ресурсу: http://jaha.ahajour­nals.org/content/4/12/e002315.





DOI: https://doi.org/10.26641/2307-0404.2017.4.117665

Refbacks

  • There are currently no refbacks.